| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 01/12/2011 | EP1604205B1 Methods of diagnosing erosive arthritis |
| 01/12/2011 | EP1402266B1 Reducing RISK OF COMPLICATIONS OF PREMATURITY |
| 01/12/2011 | CN1577272B Automatic detection and patching of vulnerable files |
| 01/12/2011 | CN101941964A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 01/12/2011 | CN101612401B Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 01/12/2011 | CN101029022B Process for the preparation of 4-phenoxy quinoline derivatives |
| 01/11/2011 | US7868168 High viscosity xanthan polymer preparations |
| 01/11/2011 | US7867976 Nogo epitopic fragments for modulating immune response |
| 01/11/2011 | US7867475 Using NK gene complex family of type II oligomeric signal transmitting receptor proteins containing C-type lectin-binding domain; increasing tumor necrosis factor alpha production; autoimmune diseases |
| 01/11/2011 | CA2518740C Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 01/11/2011 | CA2451678C Azaindoles |
| 01/11/2011 | CA2387095C Compound with growth hormone releasing properties |
| 01/11/2011 | CA2340227C Method and pharmaceutical composition for reducing serum homocysteine concentration |
| 01/06/2011 | US20110002975 Preoperative treatment of post operative pain |
| 01/06/2011 | US20110002974 Random and non-random alkylene oxide polymer alloy compositions |
| 01/06/2011 | US20110002915 Random and non-random alkylene oxide polymer alloy compositions |
| 01/06/2011 | US20110002848 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies |
| 01/05/2011 | EP2270209A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/05/2011 | EP2270023A1 New polymorphic form of 5-azacytidine |
| 01/05/2011 | EP2270022A1 New polymorphic form of 5-azacytidine |
| 01/05/2011 | EP2269651A2 Stabilisation of macrolides |
| 01/05/2011 | EP2269632A2 Immunostimulatory compositions and methods of stimulating an immune response |
| 01/05/2011 | EP2269619A1 Methods and compositions concerning poxviruses and cancer |
| 01/05/2011 | EP2269618A1 An oncolytic vaccinia virus for use in combination with a chemotherapy for treating cancer. |
| 01/05/2011 | EP2269613A2 Solid orald dosage form comprising a combination of metformin and glibenclamide |
| 01/05/2011 | EP2269604A1 Treatment of solid tumours with rapamycin derivatives |
| 01/05/2011 | EP2269603A1 Treatment of solid tumours with rapamycin derivatives |
| 01/05/2011 | EP2269579A2 Tamper-resistant products for opioid delivery |
| 01/05/2011 | EP1619498B1 Method of screening remedy for heart disease and medicinal composition for treating heart disease |
| 01/05/2011 | CN101177415B Method for preparing new crystal form of anti-cancer compound ZD1839 |
| 01/04/2011 | US7863311 administering sublingually to a horse a semisolid transmucosal gel containing detomidine, hydroxypropyl cellulose, sodium lauryl sulfate, propylene glycol and water for providing sedation and analgesia; rapid onset of action, low irritation potential in the oral mucosa |
| 01/04/2011 | US7863284 such as N-{N-{4-[N-(2-methoxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclo-penta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L- gamma -glutamyl}-D-glutamic acid, used for aiding regression and palliation of ovarian cancer; antiproliferative agents |
| 01/04/2011 | US7863250 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 01/04/2011 | US7863044 p18 in stem cell manipulations |
| 01/04/2011 | US7862816 Identifying ephrin inhibitors for use in treatment and prevention of cell proliferative and angiogenesis disorders; antitumor agents |
| 01/04/2011 | US7862815 Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP) |
| 01/04/2011 | CA2516661C M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever |
| 01/04/2011 | CA2460822C Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing same |
| 12/30/2010 | US20100331796 Ocular drug delivery device |
| 12/30/2010 | US20100331551 Alpha-haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom |
| 12/30/2010 | US20100331354 Intranasal Opioid Compositions |
| 12/30/2010 | US20100331245 Peptide yy analogs |
| 12/30/2010 | US20100330198 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue |
| 12/30/2010 | US20100330188 Carrier particles for use in dry powder inhalers |
| 12/30/2010 | US20100330101 BIFUNCTIONAL CpG OR OLIGO-/POLYNUCLEOTIDE AND TOXIN OR ENTEROTOXIN CONTAINING COMPOSITION |
| 12/29/2010 | EP2267158A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 12/29/2010 | EP2267157A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours |
| 12/29/2010 | EP2267156A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 12/29/2010 | EP2266946A2 Compound For The Treatment Of Metabolic Disorders |
| 12/29/2010 | EP2266606A1 Methods and compositions for the prevention and treatment of sepsis |
| 12/29/2010 | EP2266595A2 Treatment of infections and other disorders |
| 12/29/2010 | EP2266573A1 Fulvestrant formulation |
| 12/29/2010 | EP2266548A2 Dry powder for inhalation |
| 12/29/2010 | EP1539228B1 Novel composition and methods for the treatment of immune related diseases |
| 12/29/2010 | EP1001946B1 QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES |
| 12/29/2010 | CN1926132B Pyrazole compounds useful as protein kinase inhibitors |
| 12/29/2010 | CN1878560B Composition for topic use containing an extract of stryphnodendron, its preparation as well as its application |
| 12/29/2010 | CN101928295A Antibiotics containing borinic acid complexes and methods of use |
| 12/29/2010 | CN101928262A Biologically active methylene blue derivatives |
| 12/29/2010 | CN101926789A Improved topical medicaments and methods for photodynamic treatment of disease |
| 12/28/2010 | US7858824 Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them |
| 12/28/2010 | US7858774 Synthesis of 5-azacytidine |
| 12/28/2010 | US7858626 Pyrimidineamines as angiogenesis modulators |
| 12/23/2010 | US20100324128 9, 10-Alpha, Alpha-OH-Taxane Analogs and Methods for Production Thereof |
| 12/23/2010 | US20100324032 Compounds and uses thereof in modulating amyloid beta |
| 12/22/2010 | EP2264191A1 Asymmetrically branched polymer conjugates and microarray assays |
| 12/22/2010 | EP2264050A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof |
| 12/22/2010 | EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors |
| 12/22/2010 | EP2263690A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof |
| 12/22/2010 | EP2263689A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof |
| 12/22/2010 | EP2263686A1 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 12/21/2010 | US7855274 Recombinant factor VIII having increased specific activity |
| 12/21/2010 | US7855217 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 12/21/2010 | US7855197 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy |
| 12/21/2010 | US7855190 Non-contraceptive benefits; e.g. reducing breakthrough bleeding by administering estrogen and progestin for more than 20 consecutive days, then administering an antidepressant with estrogen over specified time range(s) |
| 12/21/2010 | US7855063 Partially deglycosylated glucocerebrosidase polypeptide and crystals thereof |
| 12/21/2010 | CA2378396C Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement |
| 12/21/2010 | CA2362858C Compositions and methods for their preparation from lepidium |
| 12/21/2010 | CA2322215C Matrix protein compositions for wound healing |
| 12/21/2010 | CA2214406C Use of penciclovir for the treatment of human herpes-virus-8 |
| 12/16/2010 | US20100317712 Estrogen Agonists/Antagonists For Preventing Breast Cancer |
| 12/16/2010 | US20100316669 Vaccine formulation potentiated by the combination of dna and an antigen |
| 12/15/2010 | EP2261244A2 Human il-18 substitution mutants and their conjugates |
| 12/15/2010 | EP2261208A1 Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 12/15/2010 | EP2261207A1 Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 12/15/2010 | EP2260844A1 Combination of an NMDA Receptor Antagonist and a Selective Serotonin Reuptake Inhibitor for the Treatment of Depression and other Mood Disorders |
| 12/15/2010 | EP1594441B1 Method for treating pain by administering a nerve growth factor antagonist and an nsaid and composition containing the same |
| 12/15/2010 | EP1076703B2 Therapeutic uses of il-17 homologous polypeptides |
| 12/15/2010 | CN1916009B Process for preparing amine platinum complexes |
| 12/15/2010 | CN1915429B Combinations of the peroxisome proliferator-activated receptor (ppar) activator and sterol absorption inhibitor |
| 12/15/2010 | CN1871342B P18 in stem cell manipulations |
| 12/15/2010 | CN1863774B Compounds and compositions as protein kinase inhibitors |
| 12/15/2010 | CN1829489B Use of buprenorphine in preparing medicine for Preoperative treatment of post operative pain |
| 12/15/2010 | CN1780596B Random and non-random alkylene oxide polymer alloy compositions |
| 12/15/2010 | CN101912615A Cladribine formulations for improved oral and transmucosal delivery |
| 12/15/2010 | CN101912421A Methods and compositions concerning poxviruses and cancer |
| 12/15/2010 | CN101912380A Compounds for the treatment of metabolic disorders |
| 12/14/2010 | US7851505 for the treatment of diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or nuclear factor kappa beta dysregulation |
| 12/14/2010 | US7851454 Short immunomodulatory oligonucleotides |
| 12/14/2010 | US7851453 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |